Videos

Michael Goodheart, MD, and Adam Dupuy, PhD, discuss the use of CRISPR technology to identify new potential treatment combinations for low-grade serous ovarian cancer.

At the SGO Annual Meeting on Women’s Cancer BJ Rimel, MD, covers cancer-related concerns for transgender and special patient populations.

At the SGO Annual Meeting on Women’s Cancer, Aaron Praiss, MD discusses the role surgical stress can play in promoting IL-6–driven tumor progression in high-grade serous ovarian cancer.

Amrita Krishnan, MD, participated in a debate about whether high-dose chemotherapy followed by autologous stem cell transplant after completion of induction therapy is the optimal frontline therapy for patients with multiple myeloma.

Michael Rosenzweig, MD, shares insights on strategies for diagnosing and treating patients with various subtypes of amyloidosis.

At the SGO Annual Meeting on Women’s Cancer, Ayesha Alvero, MD, discusses CARG-2020, and how it may be used to restore immunosurveillance and establish anti-tumoral immunological memory among patients with ovarian cancer.

At the SGO Annual Meeting on Women’s Cancer, Rebekah Peplinski, PhD candidate, discusses the potential role of Sleeping Beauty mutagenesis for identifying and understanding genes related to tumor progression in high-grade ovarian cancer.

At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Matthew Matasar, MD, discussed the importance of utilizing survivorship-focused care models and increasing the quality of life of lymphoma...

At the 2023 Great Debates & Updates in Hematologic Malignancies conference, New York, John Mascarenhas, MD, discussed recent advancements in clinical developments for the treatment of myeloproliferative neoplasms, specifically myelofibrosis,...